PH12019501225A1 - Modified streptomyces fungicidicus isolates and their use - Google Patents

Modified streptomyces fungicidicus isolates and their use

Info

Publication number
PH12019501225A1
PH12019501225A1 PH12019501225A PH12019501225A PH12019501225A1 PH 12019501225 A1 PH12019501225 A1 PH 12019501225A1 PH 12019501225 A PH12019501225 A PH 12019501225A PH 12019501225 A PH12019501225 A PH 12019501225A PH 12019501225 A1 PH12019501225 A1 PH 12019501225A1
Authority
PH
Philippines
Prior art keywords
isolates
streptomyces fungicidicus
modified streptomyces
modified
fungicidicus
Prior art date
Application number
PH12019501225A
Inventor
T Mark Zabriskie
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PH12019501225A1 publication Critical patent/PH12019501225A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention is drawn to modified Streptomyces fungicidicus isolates, to compositions comprising these isolates, and methods of using such isolates and compositions to biologically synthesize enduracidin (enramycin). In addition, the present invention is drawn to modified Streptomyces fungicidicus isolates that biologically synthesize enduracidin and facilitate the production of enramycin in a more efficient manner.
PH12019501225A 2016-12-06 2019-05-31 Modified streptomyces fungicidicus isolates and their use PH12019501225A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662430455P 2016-12-06 2016-12-06
PCT/EP2017/073771 WO2018103905A1 (en) 2016-12-06 2017-09-20 Modified streptomyces fungicidicus isolates and their use

Publications (1)

Publication Number Publication Date
PH12019501225A1 true PH12019501225A1 (en) 2019-09-23

Family

ID=60043150

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019501225A PH12019501225A1 (en) 2016-12-06 2019-05-31 Modified streptomyces fungicidicus isolates and their use

Country Status (11)

Country Link
JP (2) JP2020500509A (en)
CN (1) CN110072881A (en)
BR (1) BR112019011603A2 (en)
CO (1) CO2019005540A2 (en)
MX (1) MX2019006586A (en)
MY (1) MY194438A (en)
PE (1) PE20190967A1 (en)
PH (1) PH12019501225A1 (en)
TW (1) TWI770070B (en)
UA (1) UA127451C2 (en)
WO (1) WO2018103905A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20191767A1 (en) 2016-12-06 2019-12-17 Univ Oregon State COMPOSITIONS AND METHODS FOR THE INCREASED PRODUCTION OF ENDURACIN IN A GENETICALLY MODIFIED STREPTOMYCES FUNGICIDICUS STRAIN
CN115261258A (en) * 2022-06-07 2022-11-01 四川汇邦环保科技有限公司 Microbial agent for degrading duramycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT269354B (en) * 1965-10-13 1969-03-10 Takeda Chemical Industries Ltd Process for the production of a new antibiotic
DE1617881C2 (en) * 1965-10-13 1984-07-05 Takeda Chemical Industries, Ltd., Osaka Antibiotic enduracidin and its manufacture
US3577530A (en) 1969-07-24 1971-05-04 Squibb & Sons Inc Janiemycin
JPS6038120B2 (en) * 1980-10-31 1985-08-30 武田薬品工業株式会社 Production method of the antibiotic enzyuracydin
WO2008054945A2 (en) * 2006-09-29 2008-05-08 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Enduracidin biosynthetic gene cluster from streptomyces fungicidicus
CN101974469B (en) * 2010-10-22 2012-05-23 安徽丰原发酵技术工程研究有限公司 Streptomyces fungicidious mutant strain and application thereof
CN103374537B (en) * 2012-04-25 2015-01-07 牡丹江佰佳信生物科技有限公司 Method for preparing enduracidin and strain produced thereby
CN102864114B (en) * 2012-10-19 2013-11-06 河北圣雪大成制药有限责任公司 Strain for highly yielding enramycin, and preparation method and application thereof
CN103740612A (en) * 2013-12-19 2014-04-23 河北圣雪大成制药有限责任公司 High-yield enramycin strain and screening method thereof

Also Published As

Publication number Publication date
WO2018103905A1 (en) 2018-06-14
TW201827590A (en) 2018-08-01
MX2019006586A (en) 2019-08-22
MY194438A (en) 2022-11-30
BR112019011603A2 (en) 2020-08-18
CN110072881A (en) 2019-07-30
UA127451C2 (en) 2023-08-30
CO2019005540A2 (en) 2019-05-31
PE20190967A1 (en) 2019-07-08
JP2023012549A (en) 2023-01-25
JP2020500509A (en) 2020-01-16
RU2019117260A (en) 2021-01-11
TWI770070B (en) 2022-07-11
RU2019117260A3 (en) 2021-01-29

Similar Documents

Publication Publication Date Title
MX2023014569A (en) Anti-sirp alpha antibodies.
PH12019502283A1 (en) Anti-lag3 antibodies
PH12018501226A1 (en) Methods for treating huntingtons disease
MX2019014514A (en) Compounds for treating huntington's disease.
MX2019007020A (en) Il-11 antibodies.
MY191581A (en) Anti-pd-1 antibodies
PH12017500022A1 (en) Carrier-antibody compositions and methods of making and using the same
MX2017015473A (en) Treatment of cancer by manipulation of commensal microflora.
MD4733B1 (en) Anti-TIGIT antibodies
MX2019009117A (en) Antibodies to alpha-synuclein and uses thereof.
AU2018335389A1 (en) Nanofiber structures and methods of use thereof
MX2016016143A (en) Substituted [1,2,4]triazole compounds.
MX2015009106A (en) Solid solution compositions and use in severe pain.
MX2020014031A (en) Heterodimeric proteins and uses thereof.
MX2018009325A (en) Compounds and methods of treating rna-mediated diseases.
WO2017214170A3 (en) Baff-r antibodies and uses thereof
PH12018502137A1 (en) Anti-complement factor bb antibodies and uses thereof
MY193650A (en) Extracellular matrix compositions
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
MX2017008390A (en) Alkoxysilane-functionalized and allophanate-functionalized urethanes.
WO2020127145A3 (en) Materials for electronic devices
MX2018005785A (en) Anti-cd22 antibody-maytansine conjugates and methods of use thereof.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
PH12019501225A1 (en) Modified streptomyces fungicidicus isolates and their use